45 research outputs found
The relationship between NY-ESO-1 expression and degree of CD8 tumor infiltrating lymphocytes in TNBC.
<p>This figure shows the relationship between NY-ESO-1 expression and degree of CD8 tumor infiltrating lymphocytes in TNBC.</p
Induction of NY-ESO-1 by decitabine and 5-azacytidine.
<p>Photomicrograph showing the ability of decitabine and 5-azacytidine to induce of NY-ESO-1 <i>in vitro</i> in MCF-7 cells.</p
NY-ESO-1 expression by IHC compared with a negative IgG control.
<p>Photomicrograph of NY-ESO-1 expression by immunohistochemistry side by side compared with a negative IgG control.</p
Characteristics of NY-ESO-1 positive TNBC patients without NY-ESO-1 antibodies.
<p>Characteristics of NY-ESO-1 positive TNBC patients without NY-ESO-1 antibodies.</p
Patient characteristics.
1<p>These are not accurate reflections of the differences between TNBC and ER+/HER2- due to the sampling method.</p>2<p>LVI is lymphovascular invasion.</p
Extent of CD8 infiltration in triple negative tumors.
<p>This figure demonstrates the extent of CD8 infiltration in triple negative breast specimens.</p
PFS by NY-ESO-1 expression in TNBC.
<p>Kaplan-Meier curve showing PFS differences in patients with TNBC stratified by NY-ESO-1 expression.</p
OS by NY-ESO-1 expression in TNBC.
<p>Kaplan-Meier curve showing OS differences in patients with TNBC stratified by NY-ESO-1 expression.</p
Principal components plots of AABC and selected HapMap samples.
<p>Principal components plots of AABC and selected HapMap samples.</p